DrugPatentWatch is a software solution for businesses and organizations in the pharmaceutical and healthcare industry. The web-based platform provides comprehensive and up-to-date information on FDA approved pharmaceutical patents, drugs, and developers.
DrugPatentWatch provides a fully integrated database of drug patents and other critical information. It offers subscribers freeform searching, as well as dynamic browsing, of all types of data pertaining to pharmaceuticals and patents, whether in the US or international countries. The platform also provides data on litigation, tentative approvals, patent expirations, clinical trials, Paragraph IV challenges, top patent holders, and more.
Companies and organizations in the pharmaceutical industry can take advantage of business intelligence on biologic and small molecule drugs, drugs in development, litigation, prices, and patents to make better and more informed business decisions.
DrugPatentWatch provides organizations actionable business intelligence on small-molecule drugs. The web-based solution serves a variety of leading companies in the biopharmaceutical industry, research and development, and healthcare business.
DrugPatentWatch is a useful tool for branded pharmaceutical global business intelligence and forecasting, wholesalers who want to prevent overstocking of off-patent drugs, generic drug and API manufacturing portfolio management, and healthcare payer formulary and budget management. The service offers a variety of plans, which focuses on general business intelligence, forecasting, and expired patents.
The platform incorporates information directly from the US Food and Drug Administration (FDA), Patent and Trademark Office, and other data sources, both in the US and foreign governments. The DrugPatentWatch database is regularly updated to ensure fresh and accurate information.
For users looking to find information on expired patents, DrugPatentWatch’s annual editions offer historic archives for you to browse through, dating back all the way to the Hatch-Waxman Act. In addition to expired patents information, the DrugPatentWatch database also contains FDA-approved data on small molecule drugs and other related pharmaceutical and healthcare information. Archived copies of the FDA Orange Book are available in PDF format as well.
The DrugPatentWatch biologics dashboard covers a wide variety of search types for you to use. With a subscription, users have even more comprehensive access to the database. The platform offers a biologics dashboard, small molecule drugs dashboard, and drugs in development dashboard. Some of the search types available include:
- Search by pharmacology
- Search by drug patent expiration (by the year or by patent number)
- Search by application name
- Search by trade name
- Search patents by country (for international patents)
- Search by biologics license application
- Search by product ingredient
- Search for supplementary protection certificates
- Search by approval date (year)
- Search by finished product supplies (by trade name or by biologic ingredient)
- Search by dosage
- Search by DMF holder/company name and subject/generic name
The DrugPatentWatch small molecules dashboard allows users to manage email alerts, view a list of unapproved DESI drugs, do a search for off-patent drugs by the number of sources, as well as perform searches based on generic name/ingredient, trade name, and applicant name. The dashboard also provides access to international patent information and US regulatory and patent information.
Additionally, users may also perform a patent challenge and generic searches, as well as queries based on pharmaceutical class, dosage, formulation, raw API, finished product suppliers, and clinical trials. For a subscription, users are able to get even more comprehensive access to the platform’s complete database.
The DrugPatentWatch drugs in development dashboard provides access to patent information on drugs currently in development, patent applications, clinical trials, and vendors.
DrugPatentWatch allows pharmaceutical companies and organizations to make better business decisions by having access to a database that covers business intelligence on biologic and small molecule drugs, prices, patents, litigation, and drugs currently in development.
The web-based platform provides global biopharmaceutical business intelligence to help users identify market entry opportunities, as well as inform portfolio management decisions. It also enables businesses to sector landscaping and due diligence, as well as set up daily email alert watch lists.
DrugPatentWatch provides information on patent expiration as well as allow businesses to identify generic suppliers. The web-based service allows users to discover future therapeutic indications for drugs through biopharmaceutical forecasting. It enables you to identify first-time generic entrants and anticipate future formulary budget requirements.
Finally, DrugPatentWatch offers users the ability to keep their data by exporting it to Microsoft Excel or CSV. It also provides daily email updates and a global coverage of all major patents from more than 130 countries. Conducting searches is quick and easy, enabling users to filter and sort search results.
DrugPatentWatch offers simple flat-rate pricing for all business types in the pharmaceutical industry. The service is available in quarterly or annual plans, and they offer discount pricing for multiple users and long-term commitments. A free trial option is available and they can upgrade anytime. The following is a summary of the three subscription plans available:
Basic Plan: $1000 quarterly billing / $2995 annual billing.
- Access to US patent data
- Detailed regulatory status
- Email alerts and data export capabilities
Premium Plan: $1350 quarterly billing / $3995 annual billing.
- Everything from Basic Plan
- Access to US and international patent data
- Expired patents database
- Finished product suppliers
Ultimate Plan: $2700 quarterly billing / $7995 annual billing.
- Everything from Premium Plan
- Access to advanced patent and regulatory information
- Bulk API vendors
- Patent applications information
- Clinical trials information
Additional Modules: Available for all plans for an extra fee.
- Biologic drug patents ($1995 per year) – Includes international patents, supplier information, and SPCs.
- Drug prices ($6995 per year) – Includes average pharmacy cost, brand vs. generic pricing, and best available prices.
- Patent litigation ($3995 per year) – Includes district court and PTAB cases.
- Patents on drugs in development (Pricing available only upon request)
- Group accounts (Pricing available only upon request)
Interested parties may visit the DrugPatentWatch official website for more information about the service. You may also request a callback or a demo by completing a Request a Callback or Demo form.
DrugPatentWatch is a web-based service that provides users with access to comprehensive databases of FSA approved drugs, patent information, suppliers, information on drugs in development, developer information, and more.
The integrated databases available with the platform allow users to perform a variety of searches, from ongoing patents on pharmaceuticals to expired patents, litigations, and generic drug information based on ingredients.
Considering the expansive range of applications and the customizability made possible through various modules, it is a certainly a solution worth considering should you have the budget.